RoomsLibraryToursPeopleCompareSourcesAbout
Gemini
Exit|2 of 3 in Purdue Pharma & The Sacklers
advertorialpharma·1999 / unsealed 2002

Pushing 80mg dosage for sales bonuses

The Public Register2002
Purdue Clinical Guidelinesphysician training literature, Partners Against Pain Educational Portal
Dosing decisions must be individualized strictly according to patient pain severity and medical judgment, with safety and clinical titration leading the way.
The Private Artifact1999
Purdue National Sales Leadershipinternal sales incentive program, Internal Sales Contest Memo ('Toppers' Incentive Program)
Target doctors who prescribe 20mg and push them to titrate up to 80mg and 160mg tablets. The 80mg dose is where our highest profit margins live. Sales reps who convert low-dose prescribers will receive double bonus points and luxury resort trips.
Exhibit: OIDA_Purdue_SalesContest_1999

The Split:In clinical literature, Purdue claimed dosage was governed solely by individualized medical need. In sales compensation memos, reps were given cash incentives specifically to pressure doctors into prescribing massive 80mg doses to maximize profit margins.

The Tell (How to spot this next time):

Follow the bonus compensation structure: whatever medical ethics profess in the pamphlet, sales reps will push whatever dosage generates the highest luxury-trip multiplier.

court pipeUnsealed in state and federal opioid multidistrict litigation (MDL 2804).